6.
Cooley S, Weisdorf D, Guethlein L, Klein J, Wang T, Le C
. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010; 116(14):2411-9.
PMC: 2953880.
DOI: 10.1182/blood-2010-05-283051.
View
7.
Gonzalez-Galarza F, McCabe A, Melo Dos Santos E, Jones J, Takeshita L, Ortega-Rivera N
. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 2019; 48(D1):D783-D788.
PMC: 7145554.
DOI: 10.1093/nar/gkz1029.
View
8.
Graef T, Moesta A, Norman P, Abi-Rached L, Vago L, Older Aguilar A
. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med. 2009; 206(11):2557-72.
PMC: 2768862.
DOI: 10.1084/jem.20091010.
View
9.
Gwozdowicz S, Nestorowicz K, Graczyk-Pol E, Szlendak U, Rogatko-Koros M, Mika-Witkowska R
. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules. Int J Immunogenet. 2019; 46(4):217-231.
DOI: 10.1111/iji.12433.
View
10.
Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H
. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol. 2004; 34(6):1673-9.
DOI: 10.1002/eji.200425089.
View
11.
Hou Y, Zhang C, Xu D, Sun H
. Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus. Clin Exp Immunol. 2015; 180(2):250-4.
PMC: 4408160.
DOI: 10.1111/cei.12582.
View
12.
Jamil K, Khakoo S
. KIR/HLA interactions and pathogen immunity. J Biomed Biotechnol. 2011; 2011:298348.
PMC: 3100571.
DOI: 10.1155/2011/298348.
View
13.
Jobim M, Chagastelles P, Salim P, Portela P, Wilson T, Curti A
. Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes. Hum Immunol. 2010; 71(8):799-803.
DOI: 10.1016/j.humimm.2010.05.014.
View
14.
Jost S, Altfeld M
. Control of human viral infections by natural killer cells. Annu Rev Immunol. 2013; 31:163-94.
DOI: 10.1146/annurev-immunol-032712-100001.
View
15.
Kordasti S, Marsh J, Al-Khan S, Jiang J, Smith A, Mohamedali A
. Functional characterization of CD4+ T cells in aplastic anemia. Blood. 2011; 119(9):2033-43.
DOI: 10.1182/blood-2011-08-368308.
View
16.
Liu C, Sun Y, Shao Z
. Current Concepts of the Pathogenesis of Aplastic Anemia. Curr Pharm Des. 2019; 25(3):236-241.
DOI: 10.2174/1381612825666190313113601.
View
17.
Machado-Sulbaran A, Ramirez-Duenas M, Navarro-Zarza J, Munoz-Valle J, Mendoza-Carrera F, Banos-Hernandez C
. Gene Profile Implication in Systemic Sclerosis Patients from Mexico. J Immunol Res. 2019; 2019:6808061.
PMC: 6339729.
DOI: 10.1155/2019/6808061.
View
18.
Martin M, Qi Y, Gao X, Yamada E, Martin J, Pereyra F
. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007; 39(6):733-40.
PMC: 4135476.
DOI: 10.1038/ng2035.
View
19.
Middleton D, Gonzelez F
. The extensive polymorphism of KIR genes. Immunology. 2009; 129(1):8-19.
PMC: 2807482.
DOI: 10.1111/j.1365-2567.2009.03208.x.
View
20.
OConnor G, Guinan K, Cunningham R, Middleton D, Parham P, Gardiner C
. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol. 2006; 178(1):235-41.
DOI: 10.4049/jimmunol.178.1.235.
View